Articles tagged "Outcome"

2022 American Transplant Congress
Outcomes After Conversion to Belatacept in Pediatric Kidney Transplantation
C. Duneton, A. Maisin, E. Cheyssac, H. Dahdouh, V. Baudouin, J. Hogan
Pediatric Nephrology, Robert Debré Hospital, APHP, Paris, France
*Purpose: Belatacept (CTLA-Ig) is a selective co-stimulation blocker that is associated with reduced dnDSA, improved renal function, and prolonged allograft survival in adult transplant recipients…
2022 American Transplant Congress
25-Year Risk of ESRD Among Living Kidney Donors
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²Office of the Chief Medical Officer, UNOS, Richmond, VA
*Purpose: Previous research on post-donation ESRD in living kidney donors (LKDs) has been limited by short follow-up time, the small number of ESRD cases available…
2022 American Transplant Congress
Delayed Graft Function in Living Donor Kidney Transplantation: Risk Factors and Outcomes
G. Defelice¹, A. Paramesh², H. Jeon², K. Atiemo², M. Killackey², A. Vijay²
¹Tulane University School of Medicine, New Orleans, LA, ²Transplant Surgery, Tulane University School of Medicine, New Orleans, LA
*Purpose: Delayed graft function (DGF) following living donor kidney transplantation is less common and long-term outcomes are less understood. This single-center retrospective analysis of living…
2022 American Transplant Congress
Rates Of Dermatology Follow-up And New Skin Cancer Diagnosis Among Solid Organ Transplant Recipients During The Covid-19 Pandemic
R. Saranath, J. Gomez, B. Fernandez, E. Shah, S. Michalak, I. Ahronowitz
USC Keck School of Medicine, Los Angeles, CA
*Purpose: Solid organ transplant recipients (SOTRs) are at an elevated risk of developing non-melanoma skin cancers. Routine dermatologic surveillance has been shown to improve skin…
2022 American Transplant Congress
Attitudes Toward Organ Donation in Arab-Based Population
R. A. Almubark¹, M. Alghonaim², N. F. BinDhim³, B. Attar⁴, F. Abaalkhail⁵, F. Al Ammary⁶, S. A. Alqahtani⁷
¹Scientific Department, Sharik Association for Health Research, Riyadh, Saudi Arabia, ²CEO, Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia, ³College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, ⁴Medical Department, Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia, ⁵Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, ⁶Comprehensive Transplant Center, Johns Hopkins University, Baltimore, MD, ⁷Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD
*Purpose: Commitment to organ donation may vary among willing younger and older adults. We aimed to understand attitudes toward organ donation among Arab adults.*Methods: We…
2022 American Transplant Congress
Of the Individual Components of a Modified Freid Frailty Score, Pre-Transplant Walk Time and Grip Strength Are the Strongest Predictors of Post Kidney Transplant Outcomes
S. Parajuli, F. Aziz, H. L. Lorden, K. A. O'Toole, R. E. Wallschlaeger, I. C. Breyer, B. Dodin, J. Goronzik Wang, D. A. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Frailty assessment has become common during evaluation for kidney transplantation; however, a variety of different tools are used for frailty assessment. The Freid frailty…
2022 American Transplant Congress
Thromboelastography in Liver Transplantation: A Target Group
A. Mohamed¹, T. Kitajima¹, J. Cui¹, S. Angappan², K. Delvecchio¹, T. Shamaa¹, T. Ivanics³, S. Shimada¹, M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. Abouljoud¹, J. El-Bashir², S. Nagai¹
¹Henry Ford Transplant Institute, Detroit, MI, ²Henry Ford Hospital, Detroit, MI, ³Surgery, Henry Ford Transplant Institute, Detroit, MI
*Purpose: Liver dysfunction results in derangement of hemostasis and thrombosis. Thromboelastography (TEG) has emerged as a tool to guide resuscitative efforts. However, its utilization and…
2022 American Transplant Congress
Immunomodulation in Lung Transplant May Facilitate Transformation of Usual Interstitial Pneumonia Into Pleuroparenchymal Fibroelastosis
Q. Cai¹, K. Batra², J. R. Torrealba¹
¹Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, ²Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: Pleuroparenchymal fibroelastosis (PPFE) is a rare but distinctive manifestation of interstitial lung disease (ILD) characterized by a highly elastotic pattern of lung fibrosis. Its…
2022 American Transplant Congress
Very Small Pediatric Donors May Help Address the Sex Disparity in Access to Kidney Transplantation
J. Yu, J. Sageshima, M. Nuño, N. Mineyev, N. Goussous, R. Perez
UC Davis Medical Center, Sacramento, CA
*Purpose: Women with end-stage renal disease have lower access to deceased donor kidney transplantation than men. Expanding the donor pool to include kidneys from very…
2022 American Transplant Congress
Prospective Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) in Monitoring Response to Anti-Rejection Treatment in Kidney Transplant Recipients with Indication Biopsy
L. Benning¹, A. Fink², F. Kälble¹, C. Speer¹, C. Nusshag¹, M. Zeier¹, C. Süsal³, C. Morath¹, T. Tran²
¹Department of Nephrology, University Hospital Heidelberg, Heidelberg, Germany, ²Transplantation Immunology, Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany, ³Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a marker of allograft injury in kidney transplant recipients (KTR). Little is known about the possible use of dd-cfDNA…